首页 | 本学科首页   官方微博 | 高级检索  
   检索      

激活Toll样受体2可以促进胃癌细胞中的OXPHOS和糖酵解
引用本文:李雨哲,季承博,刘友东,顾琦晟,Brendan J. Jenkins,于 亮,李继坤.激活Toll样受体2可以促进胃癌细胞中的OXPHOS和糖酵解[J].现代生物医学进展,2022(1):6-15.
作者姓名:李雨哲  季承博  刘友东  顾琦晟  Brendan J. Jenkins  于 亮  李继坤
作者单位:上海交通大学医学院附属上海市第一人民医院普外科;哈德逊医学研究所先天免疫与传染病中心莫纳什大学临床科学学院分子转化科学系
基金项目:国家自然科学基金项目(81472236,81673034)。
摘    要:目的:调查TLR家族中哪种TLR受体的配体依赖性激活可引起胃癌细胞的代谢重编程。方法:通过实时荧光定量PCR(RT-qPCR)和蛋白质印迹(WB)在一组人GC细胞中测量TLR家族成员的表达。通过进行Seahorse生物能测定以及测量L-乳酸和活性氧(ROS)的产生,确定激动剂对不同TLR(TLR2、4、9)诱导的人GC细胞的代谢变化;通过RT-qPCR在被刺激的GC细胞中分析了涉及氧化磷酸化和糖酵解的基因的表达;通过Western印迹表征SOD2的表达。结果:由合成分子或全病原体抗原激活的TLR2信号传导增强了胃癌细胞中高表达TLR2的细胞株的糖酵解活性和线粒体呼吸,而配体诱导的TLR4和TLR9活化抑制了线粒体呼吸或细胞外酸化率。同时,涉及葡萄糖代谢和氧化还原系统调节的基因,例如HIF1A,PFKFB3和SOD2,在TLRs下游被上调。结论:由配体诱导的特定TLRs的激活介导了人类GC细胞中不同的代谢表型。TLR2是唯一同时促进OXPHOS和糖酵解的家族成员,这可能导致肿瘤进展。

关 键 词:胃癌  糖酵解  TOLL样受体  Toll样受体激动剂  OXPHOS
收稿时间:2021/4/27 0:00:00
修稿时间:2021/5/23 0:00:00

Activation of Toll-like Receptor 2 Via Specific Agonists Promotes OXPHOS and Glycolysis in Gastric Cancer Cells Rather than other Toll-like Receptors
LI Yu-zhe,JI Cheng-bo,LIU You-dong,GU Qi-sheng,Brendan J.Jenkins,YU Liang,LI Ji-kun.Activation of Toll-like Receptor 2 Via Specific Agonists Promotes OXPHOS and Glycolysis in Gastric Cancer Cells Rather than other Toll-like Receptors[J].Progress in Modern Biomedicine,2022(1):6-15.
Authors:LI Yu-zhe  JI Cheng-bo  LIU You-dong  GU Qi-sheng  Brendan JJenkins  YU Liang  LI Ji-kun
Institution:(Department of General Surgery,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,201620,China;Centre for Innate Immunity and Infectious Diseases,Hudson Institute of Medical Research,Department of Molecular Translational Science,School of Clinical Sciences,Monash University,Clayton,Victoria,3168,Australia)
Abstract:Objective: To investigate whose ligand dependent activation in the family of Toll-like receptor(TLR) is able to reprogram metabolism of gastric cancer. Methods: The m RNA and protein expression level of TLR family members in human GC cells were measured by RT-qPCR and Western blot respectively. Metabolic changes in human GC cells that were induced by agonists for various TLRs(TLR2, 4, 9) were quantified by Seahorse bioenergetic assay and production of L-lactate and ROS. The expressions of genes involved in the oxidative phosphorylation and glycolysis were also profiled in the stimulated GC cells by RT-qPCR. The protein expression level of SOD2 was quantified by Western blot. Results: The TLR2 signaling activated by either synthetic molecules or whole pathogen antigen significantly enhanced glycolytic activity and mitochondrial respiration in the cells with high level of TLR2, whereas ligand-induced activation of TLR4 and TLR9 inhibited mitochondrial respiration or extracellular acidification rate. Furthermore, the expression of genes involved in the glucose metabolism and redox system regulation, such as HIF1 A, PFKFB3 and SOD2, were upregulated. Conclusion: Our study revealed that activation of various TLRs would lead to different metabolic phenotypes in the human GC cells. Among them, TLR2 promotes both OXPHOS and glycolysis, which may contribute to the progression of gastric cancer.
Keywords:Gastric cancer  Metabolism  Toll-like receptor  Toll-like receptor agonist  OXPHOS
本文献已被 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号